ST Pharm Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
84,256
96,540
138,052
200,362
202,800
Cost of Goods Sold (COGS) incl. D&A
62,479
75,705
86,828
107,438
123,658
Gross Income
21,777
20,835
51,224
92,924
79,142
SG&A Expense
10,890
11,055
16,568
14,988
17,308
EBIT
10,851
9,716
34,469
77,583
61,834
Unusual Expense
105
111
98
3
593
Non Operating Income/Expense
1,866
2,252
4,290
3,293
3,199
Interest Expense
3,983
3,908
4,411
1,245
64
Pretax Income
9,138
4,133
35,568
80,495
59,245
Income Tax
1,570
4,013
10,413
19,069
14,248
Equity in Affiliates
107
5,347
34
-
-
Consolidated Net Income
7,461
5,466
25,189
61,426
44,997
Net Income
7,461
5,466
25,189
61,426
44,997
Net Income After Extraordinaries
7,461
5,466
25,189
61,426
44,997
Net Income Available to Common
7,461
5,466
25,189
61,426
44,997
EPS (Basic)
400.00
293.00
1,350.00
3,861.00
2,422.00
Basic Shares Outstanding
19
19
19
16
19
EPS (Diluted)
414.13
447.86
1,508.61
3,757.93
2,411.26
Diluted Shares Outstanding
19
19
19
16
19
EBITDA
15,033
14,021
40,630
88,369
73,403
Other Operating Expense
36
63
187
352
-
Non-Operating Interest Income
59
137
116
585
1,266
About ST Pharm Co.
View Profile
